Directory

>

Kathleen Meyer

avatar

Kathleen Meyer

Vice President, Nonclinical Development | Sangamo Therapeutics, Inc.

Berkeley, California, United States

View contact details (it's free)

Kathleen Meyer

Summary

Kathleen Meyer is a highly accomplished Vice President of Nonclinical Development with over 20 years of experience in the biopharmaceutical industry. She specializes in toxicology and nonclinical safety evaluation, particularly in genomic medicines and biologics. Kathleen has a proven track record of successfully navigating regulatory landscapes in the US, EU, and Japan, advocating for innovative therapeutic strategies. Her expertise spans various therapeutic areas, including oncology, diabetes, and rare diseases. Kathleen is passionate about fostering collaboration and empowering teams, which is evident in her leadership roles across multiple organizations. She holds advanced degrees in Environmental Health Sciences and Toxicology from the University of California, Berkeley, underscoring her strong academic foundation. Outside of her professional pursuits, Kathleen is likely to be an advocate for mentorship in the sciences, aiming to inspire the next generation of scientists. Her extensive publication record reflects her commitment to advancing drug development methodologies and improving patient outcomes.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Kathleen Meyer

Work Experience

company logo

Vice President, Nonclinical Development at

Sangamo Therapeutics, Inc.

January 2017 - Present

company logo

Senior Director, Toxicology at

Sangamo Biosciences, Inc.

January 2014 - December 2016

company logo

Principal at

Dean Nonclinical Consulting, Inc.

February 2013 - December 2016

company logo

Principal Scientist at

BioMarin Pharmaceutical Inc.

March 2012 - February 2013

company logo

Senior Director, Preclinical Safety Evaluation at

XOMA Royalty

June 2009 - February 2012

💼

Director, Preclinical Safety Evaluation at

Xoma

January 2008 - June 2009

💼

Director, Toxicology at

Xoma

October 2005 - January 2008

💼

Group Leader at

Xoma

January 2003 - January 2005

company logo

Principal Scientist at

Elan Pharmaceuticals

January 2001 - February 2003

💼

Senior Scientist II at

Xoma

January 2003 - January 2003

company logo

Scientist at

Elan Pharmaceuticals

June 1997 - January 2001

💼

Histologist/Pathology Department at

Syntex Research

January 1981 - January 1987

Logos provided by Logo.dev

Kathleen Meyer

Education

University of California, Berkeley, Master Degree In Public Health (Mph)

University of California, Berkeley, Doctor Of Philosophy (Phd)

University of California, Berkeley, Bachelor Of Arts (Ba)

Frequently Asked Questions about Kathleen Meyer

What is Kathleen Meyer email address?

Kathleen Meyer's primary email address is *****@xoma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kathleen Meyer work for?

Kathleen Meyer is a Vice President, Nonclinical Development at Sangamo Therapeutics, Inc., a company specializing in Commercial physical research.

Where Kathleen Meyer graduated from?

Kathleen Meyer holds a degree in Specializing In Toxicology from University of California, Berkeley.

How can I directly contact Kathleen Meyer?

To contact Kathleen Meyer directly, you can use the email address *****@xoma.com. Complete contact information is available upon registration with Muraena.

Who is Kathleen Meyer?

Kathleen Meyer is a highly accomplished Vice President of Nonclinical Development with over 20 years of experience in the biopharmaceutical industry. She specializes in toxicology and nonclinical safety evaluation, particularly in genomic medicines and biologics. Kathleen has a proven track record of successfully navigating regulatory landscapes in the US, EU, and Japan, advocating for innovative therapeutic strategies. Her expertise spans various therapeutic areas, including oncology, diabetes, and rare diseases. Kathleen is passionate about fostering collaboration and empowering teams, which is evident in her leadership roles across multiple organizations. She holds advanced degrees in Environmental Health Sciences and Toxicology from the University of California, Berkeley, underscoring her strong academic foundation. Outside of her professional pursuits, Kathleen is likely to be an advocate for mentorship in the sciences, aiming to inspire the next generation of scientists. Her extensive publication record reflects her commitment to advancing drug development methodologies and improving patient outcomes.

Kathleen`s contact details

mail

*****@xoma.com

******@sangamo.com

Colleagues

avatar
Phillip Ramsey

SVP Technical Operations

Andy Ramelmeier

Executive Vice President Technical Operations

avatar
Antonio Vernacchio

Vice President, Global Manufacturing and Supply Chain

avatar
Gregory Davis

VP, Head of Research and Technology

avatar
Tae Bum Shin

Vice President, Intellectual Property

avatar
Sandy Macrae

Chief Executive Officer

avatar
Scott Willoughby

Senior Vice President, General Counsel & Corporate Secretary

avatar
Nathalie Dubois-Stringfellow

Chief Development Officer

avatar
Richard Boismenu

Scientific Advisor

Gillian Atkinson

Vice President Autoimmune Franchise, Product Development

View Contact details (it's free)
Request Profile Removal